Browse > Article

The Consideration of nuclear medicine technologist's occupational dose from patient who are undergoing 18F-FDG Whole body PET/CT : Aspect of specific characteristic of patient and contact time with patient  

Kim, Sunghwan (Department of Nuclear Medicine, Asan medical Center)
Ryu, Jaekwang (Department of Nuclear Medicine, Asan medical Center)
Ko, Hyunsoo (Department of Nuclear Medicine, Asan medical Center)
Publication Information
The Korean Journal of Nuclear Medicine Technology / v.22, no.1, 2018 , pp. 67-75 More about this Journal
Abstract
Purpose The purpose of this study is to investigate and analyze the external dose rates of $^{18}F-FDG$ Whole Body PET/CT patients by distance, and to identify the main factors that contribute to the reduction of radiation dose by checking the cumulative doses of nuclear medicine technologist(NMT). Materials and Methods After completion of the $^{18}F-FDG$ Whole Body PET/CT scan($75.4{\pm}3.3min$), the external dose rates of 106 patients were measured at a distance of 0, 10, 30, 50, and 100 cm from the chest. Gender, age, BMI(Body Mass Index), fasting time, diabetes mellitus, radiopharmaceutical injection information, creatine value were collected to analyze individual factors that could affect external dose rates from a patient's perspective. From the perspective of NMT, personal pocket dosimeters were worn on the chest to record accumulated dose of NMT who performed the injection task($T_1$, $T_2$ and $T_3$) and scan task($T_4$, $T_5$ and $T_6$). In addition, patient contact time with NMT was measured and analyzed. Results External dose rates from the patient for each distance were calculated as $246.9{\pm}37.6$, $129.9{\pm}16.7$, $61.2{\pm}9.1$, $34.4{\pm}5.9$, and $13.1{\pm}2.4{\mu}Sv/hr$ respectively. On the patient's aspect, there was a significant difference in the proximity of gender, BMI, Injection dose and creatine value, but the difference decreased as the distance increased. In case of dialysis patient, external dose rates for each distance were exceptionally higher than other patients. On the NMT aspect, the doses received from patients were 0.70, 1.09, $0.55{\mu}Sv/person$ for performing the injection task($T_1$, $T_2$, and $T_3$), and were 1.25, 0.82, $1.23{\mu}Sv/person$ for performing the scan task($T_4$, $T_5$, $T_6$). Conclusion we found that maintaining proper distance with patient and reducing contact time with patient had a significant effect on accumulated doses. Considering those points, efforts such as sufficient water intake and encourage of urination, maintaining the proper distance between the NMT and the patient(at least 100 cm), and reducing the contact time should be done for reducing dose rates not only patient but also NMT.
Keywords
Nuclear medicine technologist(NMT); External dose rates; Individual factor;
Citations & Related Records
연도 인용수 순위
  • Reference
1 박훈희, 이정배, 정필균, 이종두, 원종욱, 노재훈. PET, PET/CT 방사선 종사자의 피폭 관련요인. Korean J Occup Environ Med, 2012;24(1):86-95.   DOI
2 Bloe F, Williams A. Personnel monitoring observations. J Nucl Med. 0000;00(0):00-00.
3 Chiesa C, De Sanctis V, Crippa F et al. Radiation dose to technicians per nuclear medicine procedure: comparison between technetium-99m, gallium-67 and iodine-131 radiotracers and fluorine-18 fluorodeoxyglucose. Eur J Nucl Med. 1997; 24:1380-9.   DOI
4 Kearfott KJ, Carey JE, Clemenshaw MN, Faulkner DB. Radiatio protection design for a clinical positron emission tomography imaging suite. Health Phys. 1992; 63:581-9.   DOI
5 Smith D S and Stabin M 2012 Exposure rate constants and lead shielding values for over 1,100 radionuclides Health Physics. 102 271-91.   DOI
6 Richard L. Wahl, Julia W. Buchanan Principles and Practice of Positron Emission Tomography. LIPPINCOTT WILLIAMS & WILKINS. 2002: 100-110.
7 Hyun SH, Ahn HK, Lee JH, Choi JY, Kim B-T, Park YH, et al. (2016) Body Mass Index with Tumor $^{18}F$-FDGUptake Improves Risk Stratification in Patients with Breast Cancer. PLoSONE11(10): e0165814.doi: 10.1371/journal.pone. 0165814.
8 TracercoTM PERSONAL ELECTRONIC DOSIMETER (PED) User Manual. P. 24.
9 Niven E, Thompson M, Nahmias C. Absorbed dose to the adult male and female brain from $^{18}F$-Fluorodeoxyglucose. Health Phys. 2001;80:62-6.   DOI
10 Aruna Kaushik, Abhinav Jaimini1, Madhavi Tripathi1. Estimation of patient dose in $^{18}F$-FDG and $^{18}F$-FDOPAPET/CTexaminations. 0000;00(0):00-00.   DOI
11 Harvey J, Firnau G, Garnett ES. Estimation of radiation dose in man due to 6-[18F]fluoro-L-dopa. J Nucl Med. 1985;26:931-5.
12 Cho IH, Han EO, Kim ST. Very different external radiation doses in patients undergoing PET/CT or PET/MRI scans and factors affecting them. Hellenic Journal of Nuclear Medicine. 01 Jan 2014, 17(1):13-18
13 Matthew T. Studenskia. Effective dose to patients and staff when using a mobile PET/SPECT system. JOURN AL OF APPLIED CLINICAL MEDICAL PHYSICS. VOLUME14, NUMBER3, 2013.
14 Ronald B. FDG PET/CT: EANM procedure guidelines for tumour imaging: version 2.0. Eur J Nucl Med Mol Imaging. 2015; 42: 328-354.   DOI
15 고현수, 김호성, 남궁창경, 윤순상, 송재혁, 류재광, et al. A study on the strategies to lower technologist occupational exposure according to the performance form in PET scan procedure. 0000;00(0):00-00.
16 Robinson CN, Young JG, Ibbetson VJ. A study of the personal radiation dose received by nuclear medicine technologists working in a dedicated PET center. Health Phys. 2005;88(suppl 1):17S-21S.   DOI
17 Masuda Y, Kondo C, Matsuo Y, Uetani M, Kusakabe K. Comparison of imaging protocols for 18F-FDG PET/CT in overweight patients: optimizing scan duration versus administered dose. J Nucl Med. 2009;50(6):844-8.   DOI